What is the best oral medication to switch to from cefepime (Cefepime)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Oral Medication Switch from Cefepime

The best oral medication to switch from cefepime is a fluoroquinolone (levofloxacin 750mg or ciprofloxacin 500mg twice daily) when treating Pseudomonas aeruginosa infections, as these provide the most reliable oral coverage against Pseudomonas species. 1, 2

Selection Algorithm Based on Suspected Pathogen

For Pseudomonas aeruginosa infections:

  • First choice: Levofloxacin 750mg daily or Ciprofloxacin 500mg twice daily 1, 2
    • These are the only reliable oral options for Pseudomonas coverage
    • Levofloxacin 750mg daily is preferred for better compliance

For non-Pseudomonal infections:

  1. Community-acquired pneumonia:

    • Moxifloxacin 400mg daily or Levofloxacin 500mg daily 1
    • Alternative: Amoxicillin-clavulanate 875mg twice daily 1
  2. Intra-abdominal infections:

    • Ciprofloxacin 500mg twice daily + Metronidazole 500mg three times daily 1
    • Alternative: Amoxicillin-clavulanate 875mg twice daily 1
  3. Urinary tract infections:

    • Ciprofloxacin 500mg twice daily or Levofloxacin 750mg daily 1
    • Alternative: Trimethoprim-sulfamethoxazole DS tablet twice daily 1

Considerations for Specific Pathogens

Organism Preferred Oral Option
Pseudomonas aeruginosa Ciprofloxacin 500mg BID or Levofloxacin 750mg daily [1,2]
ESBL-producing organisms Fluoroquinolones (if susceptible) [1]
Streptococcus pneumoniae Moxifloxacin 400mg daily (highest antipneumococcal activity) [1]
Staphylococcus aureus (MSSA) Amoxicillin-clavulanate 875mg BID [1]
Acinetobacter baumannii No reliable oral options; consider prolonged IV therapy [1]

Important Clinical Considerations

  1. Timing of switch: Only switch to oral therapy when the patient:

    • Has clinical improvement in symptoms
    • Is afebrile for at least 24 hours
    • Has a functioning gastrointestinal tract
    • Has decreasing white blood cell count 1
  2. Duration of therapy:

    • Community-acquired pneumonia: 5-7 days 1
    • Hospital-acquired pneumonia: 7-10 days 1
    • Complicated intra-abdominal infections: 5-10 days 1
    • Bloodstream infections: 10-14 days 1
  3. Pitfalls to avoid:

    • Don't use oral cephalosporins (like cefixime) for Pseudomonas coverage as they lack reliable activity 3
    • Fluoroquinolone resistance is increasing in many regions; check local susceptibility patterns 1
    • Consider the risk of C. difficile infection with prolonged fluoroquinolone use
    • For difficult-to-treat resistant Pseudomonas, oral options are limited; may need to continue IV therapy 1

Special Populations

  • Patients with bronchiectasis: Ciprofloxacin 750mg twice daily for 14 days, followed by inhaled antibiotics if chronic colonization 1, 2
  • Patients with cystic fibrosis: Higher doses of ciprofloxacin (750mg twice daily) may be needed 2
  • Elderly patients: Consider dose adjustment for fluoroquinolones based on renal function

Remember that cefepime has excellent activity against Pseudomonas aeruginosa 4, 5, 6, and finding an oral equivalent with similar coverage is challenging. Fluoroquinolones represent the only reliable oral option for Pseudomonas coverage, but their efficacy may be compromised by increasing resistance rates.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pseudomonas Aeruginosa Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cefepime clinical pharmacokinetics.

Clinical pharmacokinetics, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.